NACL Industries Reports ₹3.83 Billion Q1 Revenue, Divests Subsidiary Stake

HYDERABAD, India — Agrochemical manufacturer NACL Industries Limited (NSE: NCLIND, BSE: 524709) announced its first-quarter financial results for the period ended June 30, 2026, alongside a corporate divestment proposal on Wednesday, July 22, 2026.

In regulatory disclosures submitted to domestic stock exchanges under SEBI guidelines, the Hyderabad-headquartered company posted consolidated revenue from operations of ₹3.83 billion (₹383 crore) for Q1 FY27. Consolidated net profit after tax reached ₹208.4 million (₹20.84 crore). Additionally, the Board of Directors approved a proposal to sell the equity shares held by the company in Nasense Labs Private Limited for a total consideration of ₹81.5 million (₹8.15 crore).

Financial Breakdown and Divestment Terms

The financial performance reflects seasonal demand for crop protection formulations and technical-grade active ingredients during the early Kharif sowing season.

The sale of equity shares in Nasense Labs forms part of NACL Industries' capital allocation strategy to monetize non-core investments, optimize its portfolio structure, and streamline balance sheet resources toward core agrochemical manufacturing operations in Andhra Pradesh and Gujarat.

Sector Context and Operational Strategy

The domestic agrochemical sector experienced stable demand for herbicides, insecticides, and fungicides supported by monsoon progression across major agricultural belts in southern and central India.

Market analysts note that the proceeds from the ₹81.5 million stake sale will provide incremental liquidity to support working capital requirements and debt servicing.

Official Sources Section

Financial results, limited review reports, and board meeting outcomes were formally filed with the National Stock Exchange of India (NSE) and BSE Limited pursuant to SEBI Listing Regulations, with corporate details hosted on the NACL Industries Official Website.

Quote Section

"According to corporate disclosures filed with domestic stock exchanges on July 22, 2026, NACL Industries Limited generated ₹3.83 billion in consolidated revenue from operations with a net profit of ₹208.4 million for Q1 FY27, while the board approved the sale of its equity stake in Nasense Labs for ₹81.5 million."

Why It Matters

• For Equity Shareholders: Demonstrates stable top-line performance alongside strategic balance sheet streamlining through non-core asset sales.

• For Agriculture Sector Observers: Indicates steady demand for domestic crop protection chemicals during the primary Kharif planting window.

• For Corporate Credit Analysts: Confirms positive liquidity generation through combined operational net profits and equity divestment proceeds.

Key Facts at a Glance

• Q1 Revenue from Operations: ₹3.83 billion (₹383 crore).

• Q1 Consolidated Net Profit: ₹208.4 million (₹20.84 crore).

• Divestment Deal: Sale of Nasense Labs Private Limited equity shares for ₹81.5 million.

• Exchange Tickers: NSE: NCLIND (NACL.NS), BSE: 524709.

Frequently Asked Questions (FAQ)

What was NACL Industries' net profit for the June quarter?

NACL Industries reported a consolidated net profit of ₹208.4 million (₹20.84 crore) for the quarter ended June 30, 2026.

How much is NACL Industries selling its stake in Nasense Labs for?

The Board of Directors approved the sale of its equity holding in Nasense Labs Private Limited for ₹81.5 million (₹8.15 crore).

On which stock exchanges is NACL Industries listed?

NACL Industries Limited is listed on the National Stock Exchange of India (NSE) under ticker symbol NCLIND (NACL.NS) and on BSE Limited under scrip code 524709.

Source: Official regulatory financial statements submitted to the National Stock Exchange of India (NSE) and BSE Limited by NACL Industries Limited, with corporate disclosures archived by Reuters.